Skip to main content
Premium Trial:

Request an Annual Quote

Australia's UQ Wins $1M in Grants for Molecular Biology Research Facilities

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australia's University of Queensland has awarded a combined A$1.03 million ($997,293) in grants for three projects designed to improve UQ's facilities for molecular biology research:

The grants include:

• A$550,000 to Paul Alewood of UQ's Institute for Molecular Bioscience, toward a high-throughput, high-resolution protein-peptide sequencing and quantification facility. The facility is designed to assist UQ scientists using mass spectrometry to elucidate the structures of toxins that have potential to be developed as drugs.

• A$240,000 to Timothy Bredy of the Queensland Brain Institute toward a mass spectrometry platform for high-throughput genotyping, epigenetic analysis, and validation of genome-wide sequencing studies. The platform is intended to provide a platform for Australian researchers to quantitatively measure genetic information in a rapid, accurate, and cost-efficient.

• A$240,000 to Jochen Mueller of the National Research Centre for Environmental Toxicology toward an ultra-high-performance liquid chromatography ion trap mass spectrometer to develop new capabilities in environmental and human toxicology. The mass spec will be used for developing methods and analyses of environmental contaminants and by-products, underpinning research in environmental toxicology and chemistry.

The three projects were among 10 UQ projects that were awarded a combined A$3.6 million through the Australian Research Council's 2011 Linkage Infrastructure, Equipment and Facilities program. The university said it won the second largest share of the A$30 million awarded to institutions across Australia.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.